• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义 ALG1 基因突变导致的糖基化先天性紊乱的表型。

Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations.

机构信息

Department of Pediatrics at the Institute for Genetic and Metabolic Diseases, Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB Nijmegen, The Netherlands.

出版信息

Pediatrics. 2012 Oct;130(4):e1034-9. doi: 10.1542/peds.2011-2711. Epub 2012 Sep 10.

DOI:10.1542/peds.2011-2711
PMID:22966035
Abstract

Deficiency of β-1,4 mannosyltransferase (MT-1) congenital disorder of glycosylation (CDG), due to ALG1 gene mutations. Features in 9 patients reported previously consisted of prenatal growth retardation, pregnancy-induced maternal hypertension and fetal hydrops. Four patients died before 5 years of age, and survivors showed a severe psychomotor retardation. We report on 7 patients with psychomotor delay, microcephaly, strabismus and coagulation abnormalities, seizures and abnormal fat distribution. Four children had a stable clinical course, two had visual impairment, and 1 had hearing loss. Thrombotic and vascular events led to deterioration of the clinical outcome in 2 patients. Four novel ALG1 mutations were identified. Pathogenicity was determined in alg1 yeast mutants transformed with hALG1. Functional analyses showed all novel mutations representing hypomorphs associated with residual enzyme activity. We extend the phenotypic spectrum including the first description of deafness in MT1 deficiency, and report on mildly affected patients, surviving to adulthood. The dysmorphic features, including abnormal fat distribution and strabismus highly resemble CDG due to phosphomannomutase-2 deficiency (PMM2-CDG), the most common type of CDG. We suggest testing for ALG1 mutations in unsolved CDG patients with a type 1 transferrin isoelectric focusing pattern, especially with epilepsy, severe visual loss and hemorrhagic/thrombotic events.

摘要

β-1,4 甘露糖基转移酶(MT-1)缺陷型先天性糖基化障碍(CDG),由 ALG1 基因突变引起。先前报道的 9 例患者的特征包括产前生长迟缓、妊娠引起的母亲高血压和胎儿水肿。4 名患者在 5 岁之前死亡,幸存者表现出严重的精神运动发育迟缓。我们报告了 7 例精神运动发育迟缓、小头畸形、斜视和凝血异常、癫痫发作和脂肪分布异常的患者。4 名儿童的临床病程稳定,2 名儿童视力受损,1 名儿童听力受损。血栓形成和血管事件导致 2 名患者的临床预后恶化。发现了 4 个新的 ALG1 突变。在转化为 hALG1 的 alg1 酵母突变体中确定了致病性。功能分析表明,所有新突变均代表与残留酶活性相关的低功能突变体。我们扩展了表型谱,包括首次描述 MT1 缺陷型耳聋,并报告了轻度受影响的患者,可存活至成年。发育异常特征,包括脂肪分布异常和斜视,与磷酸甘露糖变位酶-2 缺陷型(PMM2-CDG)非常相似,后者是最常见的 CDG 类型。我们建议对 1 型转铁蛋白等电聚焦模式的未解决 CDG 患者进行 ALG1 突变检测,特别是有癫痫、严重视力丧失和出血/血栓事件的患者。

相似文献

1
Defining the phenotype in congenital disorder of glycosylation due to ALG1 mutations.定义 ALG1 基因突变导致的糖基化先天性紊乱的表型。
Pediatrics. 2012 Oct;130(4):e1034-9. doi: 10.1542/peds.2011-2711. Epub 2012 Sep 10.
2
ALG1-CDG: a new case with early fatal outcome.ALG1-CDG:一例早期致死的新病例。
Gene. 2014 Jan 25;534(2):345-51. doi: 10.1016/j.gene.2013.10.013. Epub 2013 Oct 21.
3
Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations.鸟苷二磷酸甘露糖:葡萄糖胺 2-N-乙酰基转移酶缺陷(糖基化障碍 I 型):五例新病例和七个新突变。
J Med Genet. 2010 Nov;47(11):729-35. doi: 10.1136/jmg.2009.072504. Epub 2010 Aug 2.
4
DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.DPM2-CDG:一种伴有严重癫痫的肌肉营养不良症- dystroglycanopathy 综合征。
Ann Neurol. 2012 Oct;72(4):550-8. doi: 10.1002/ana.23632.
5
Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.磷酸多萜醇甘露糖合成酶-1缺乏会导致Ie型先天性糖基化障碍。
J Clin Invest. 2000 Jan;105(2):233-9. doi: 10.1172/JCI8691.
6
Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik.N-糖基化途径中首个甘露糖基化步骤的缺陷会导致Iκ型先天性糖基化障碍。
Hum Mol Genet. 2004 Mar 1;13(5):535-42. doi: 10.1093/hmg/ddh050. Epub 2004 Jan 6.
7
ALG1-CDG: Clinical and Molecular Characterization of 39 Unreported Patients.ALG1-CDG:39例未报告患者的临床和分子特征
Hum Mutat. 2016 Jul;37(7):653-60. doi: 10.1002/humu.22983. Epub 2016 Mar 21.
8
Improved diagnostics lead to identification of three new patients with congenital disorder of glycosylation-Ip.改良的诊断方法导致了 3 例先天性糖基化障碍-Ip 新病例的确诊。
Hum Mutat. 2012 Mar;33(3):485-7. doi: 10.1002/humu.22019. Epub 2012 Jan 31.
9
29 French adult patients with PMM2-congenital disorder of glycosylation: outcome of the classical pediatric phenotype and depiction of a late-onset phenotype.29例患有PMM2先天性糖基化障碍的法国成年患者:经典儿科表型的结局及迟发型表型的描述
Orphanet J Rare Dis. 2014 Dec 11;9:207. doi: 10.1186/s13023-014-0207-4.
10
PMM2-CDG: phenotype and genotype in four affected family members.庞贝病 2 型糖原贮积症:4 名受累家庭成员的表型和基因型。
Gene. 2013 Dec 1;531(2):506-9. doi: 10.1016/j.gene.2013.07.083. Epub 2013 Aug 26.

引用本文的文献

1
Case Report of Friedreich's Ataxia and ALG1 -Related Biochemical Abnormalities in a Patient With Progressive Spastic Paraplegia.一例进行性痉挛性截瘫患者合并弗里德赖希共济失调及ALG1相关生化异常的病例报告
Am J Med Genet A. 2025 Feb;197(2):e63890. doi: 10.1002/ajmg.a.63890. Epub 2024 Sep 26.
2
Normal transferrin glycosylation does not rule out severe ALG1 deficiency.正常的转铁蛋白糖基化并不能排除严重的ALG1缺乏症。
JIMD Rep. 2024 Apr 16;65(3):135-143. doi: 10.1002/jmd2.12415. eCollection 2024 May.
3
Dysregulated proteome and N-glycoproteome in ALG1-deficient fibroblasts.
ALG1 缺陷型成纤维细胞中失调的蛋白质组和 N-糖蛋白组。
Proteomics. 2024 Aug;24(15):e2400012. doi: 10.1002/pmic.202400012. Epub 2024 Mar 12.
4
A novel variant in ALG1 gene associated with congenital disorder of glycosylation: A case report and short literature review.ALG1 基因中的一种新型变异与糖基化先天性疾病相关:病例报告及文献复习。
Mol Genet Genomic Med. 2023 Aug;11(8):e2197. doi: 10.1002/mgg3.2197. Epub 2023 May 19.
5
Perinatal manifestations of congenital disorders of glycosylation-A clue to early diagnosis.糖基化先天性疾病的围产期表现——早期诊断的线索
Front Genet. 2022 Dec 13;13:1019283. doi: 10.3389/fgene.2022.1019283. eCollection 2022.
6
ALG1-CDG: A Patient with a Mild Phenotype and Literature Review.ALG1-先天性糖基化障碍:一名具有轻度表型的患者及文献综述
Mol Syndromol. 2022 Feb;13(1):69-74. doi: 10.1159/000517797. Epub 2021 Sep 21.
7
ALG1-CDG Caused by Non-functional Alternative Splicing Involving a Novel Pathogenic Complex Allele.由涉及新型致病复合等位基因的无功能可变剪接引起的ALG1-CDG
Front Genet. 2021 Sep 9;12:744884. doi: 10.3389/fgene.2021.744884. eCollection 2021.
8
Congenital Disorders of Glycosylation from a Neurological Perspective.从神经学角度看先天性糖基化障碍
Brain Sci. 2021 Jan 11;11(1):88. doi: 10.3390/brainsci11010088.
9
Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function.新型 O-连接糖基化发育障碍由 GALNT2 功能丧失引起。
Brain. 2020 Apr 1;143(4):1114-1126. doi: 10.1093/brain/awaa063.
10
Loss-of-function mutations in UDP-Glucose 6-Dehydrogenase cause recessive developmental epileptic encephalopathy.UDP-葡萄糖 6-脱氢酶功能丧失突变导致隐性发育性癫痫性脑病。
Nat Commun. 2020 Jan 30;11(1):595. doi: 10.1038/s41467-020-14360-7.